Great Debates & Updates in Oncology Pharmacy attracts the nation's leading minds in oncology pharmacy to share optimal treatment strategies, discuss forward-thinking topics, and provide practical takeaways to help attendees improve patient outcomes through education.
Meet the Co-Chairs
Val R. Adams, PharmD, FHOPA, FCCP, BCOP
University of Kentucky
Dr. Adams is an Associate Professor in the department of Pharmacy Practice and Science in the College of Pharmacy at the University of Kentucky. He is on the graduate faculty and is a member of the Markey Cancer Center where he has a clinical practice site. He co-chairs the protocol review and monitoring committee for the NCI Designated Markey Cancer center. He served as the director of the hematology / oncology residency program for 20 years and has trained forty PGY2 oncology residents and maintains an active research program. He has trained two post-doctoral fellows, been the thesis advisor for 7 masters students, and served on 23 PhD dissertation student committees and was advisor or co-advisor for 7 of them. He received his B.S. in pharmacy from the University of Utah and received his doctor of pharmacy from the University of Texas at Austin jointly with the University of Texas Health Science Center at San Antonio. He completed a residency in hematology / oncology at the Audie L. Murphy Memorial V.A. Hospital in San Antonio, Texas. He then completed a two-year fellowship in immunology and transplantation at the University of Florida. Following the completion of the fellowship he joined the University of Kentucky faculty in 1996.
Christopher Fausel, PharmD, MHA, BCOP
Clinical Manager, Oncology Pharmacy
Indiana University Health
Christopher Fausel, Pharm.D. MHA BCOP is the Precision Genomics Oncology Pharmacist at the Indiana University Simon Cancer Center (IUSCC) in Indianapolis, Indiana. He graduated from Albany College of Pharmacy with a BS Pharmacy in 1993 and Pharm.D. in 1996 and completed residency training at the Stratton VA Medical Center in Albany, NY. In addition, he is the Chairman of the Board of the Hoosier Oncology Group, a non-profit organization that conducts clinical trials and translational research in cancer and is the administrative headquarters of the Big Ten Cancer Research Consortium. He is the founding Residency Program Director for the PGY2 Oncology Pharmacy Residency and has previously served as a clinical specialist in hematology/oncology/stem cell transplant and as a clinical manager for oncology pharmacy for over 20 years at Indiana University Health. He is a Chair for the Indiana University biomedical IRB. He is a long-standing member of ASHP, ASCO and HOPA.
Kirollos S. Hanna, PharmD, BCPS, BCOP
Oncology Pharmacy Manager
M Health Fairview - Maple Grove
Assistant Professor of Pharmacy
Mayo Clinic College of Medicine
Dr. Hanna is board certified by the Board of Pharmacy Specialties in Oncology Pharmacy and Pharmacotherapy. He received his doctorate of pharmacy from Florida A&M University, completed his general residency at St. Thomas Hospital, Nashville, TN and his oncology residency at St. Luke's Mountain States Tumor Institute, Boise, ID. He is currently an Assistant Professor of Pharmacy at the Mayo Clinic College of Medicine and the Oncology Pharmacy Manager at M Health Fairview, Maple Grove.
Dr. Hanna’s research interests are focused on outcome measures for patients with rare diseases, B-cell malignancies, and genitourinary cancers. He has published over a dozen peer-reviewed manuscripts in various journals including Pharmacotherapy, AJHP, JOPP, AJMC and JHOP. He is a member of the Executive Council for the National Community Oncology Dispensing Association (NCODA) and is an active member of numerous professional organizations including ACCC, HOPA, and ACCP.
Lisa Holle, PharmD, BCOP, FHOPA, FISOPP
UConn School of Pharmacy
UConn Health Carole and Ray Neag Comprehensive Cancer Center
Dr. Holle completed her Bachelor of Science in Pharmacy and post-baccalaureate Doctor of Pharmacy from the University of Wisconsin–Madison. She completed a specialized oncology residency at UT M.D. Anderson Cancer Center, and is a board-certified oncology pharmacist. Dr. Holle has worked as an oncology pharmacist for over 20 years in a variety of settings including private hospitals, academic medical centers, and medical communications. Currently, Dr. Holle is an Associate Clinical Professor at the UConn School of Pharmacy and Associate Professor at the UConn School of Medicine. Her practice site is at the UConn Health Carole and Ray Neag Comprehensive Cancer Center, where she works in a team-based ambulatory care clinic focusing on genitourinary and gastrointestinal cancers.
Dr. Holle is a Past President of HOPA and a past Secretariat member and Treasurer of the International Society of Oncology Pharmacy Practitioners (ISOPP). She is also an active member in many other professional oncology and pharmacy organizations. Dr. Holle’s clinical research program focuses on numeracy and patient decision-making, oncology quality improvement initiatives, medical marijuana, and oral anticancer therapy management. She has authored numerous articles and chapters on oncology and teaching-related topics.